About: Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis-related interstitial lung disease

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis-related interstitial lung disease Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 30 December 2016

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) artículu científicu espublizáu en 2016 (ast) наукова стаття, опублікована в грудні 2016 (uk) scientific article published on 30 December 2016 (en) مقالة علمية نشرت في 30 ديسمبر 2016 (ar)
publication date	wds:Q37547111-5290A0D9-44A3-4E7B-9FD3-3D8CA0438993
publication date	2016-12-30 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37547111-1D140228-ABD9-40F8-A856-63ED97700297
language of work or name	English
exact match	wds:Q37547111-7530982C-48B8-4D01-9B1A-9B46A9B1D3BF
exact match	https://scigraph.springernature.com/pub.10.1186/s13075-016-1203-y
cites work	wds:Q37547111-13914898-C469-4EF7-BE63-CF4D02E52830 wds:Q37547111-215224DE-FD7F-4076-B709-BDAC73BAF807 wds:Q37547111-21695549-636C-45E3-8019-2C202AEC8CE0 wds:Q37547111-30EA6767-288E-44FA-9BDA-ED66C491394F wds:Q37547111-465FD77F-6CEE-4F71-BCB1-68836CABDE5D wds:Q37547111-52C06701-6E33-41AD-83F8-95C972F4282D wds:Q37547111-546A3B46-C999-459C-A6DF-266D59111D4F wds:Q37547111-5FA49E17-97FB-47B1-9491-DFCA54AE44D1 wds:Q37547111-604CC5F0-8E48-456F-AA82-C36229E8C5A5 wds:Q37547111-6DC0DC62-9DF1-4263-83BA-ADFD727D3827 wds:Q37547111-768AF1F3-7143-449B-A3B8-412A85A94CCD wds:Q37547111-86D29386-1107-4764-A9F0-89F1C4F6876B wds:Q37547111-892C6A11-252C-4498-AA2C-09F376D64773 wds:Q37547111-8CC43AC1-B8B1-4D49-9F43-1D8A9A93E814 wds:Q37547111-B1CFE6F9-1DEB-408E-AC48-B7EF210693B7 wds:Q37547111-B461031D-A5E5-47B6-81C2-179B33AD85BB wds:Q37547111-B50FC2E2-A329-4878-BE68-58A34AB1C658 wds:Q37547111-B98A734A-6470-499E-860D-1BD9D17AA072 wds:Q37547111-DBC09BF7-7B73-4600-B9EC-EFFEA1EC0927 wds:Q37547111-DE1F6E3D-5A16-4F17-92E5-A2839483E862 wds:Q37547111-E9D2268F-F83D-45C1-898B-6CEB301FEBFF wds:Q37547111-ECF280AE-F2BF-494F-8F4A-6FC41BEE1FCB wds:Q37547111-F28C5B58-150C-4A35-B916-458BBD83E35E wds:Q37547111-F80C6C44-FA2B-437C-8294-B5B7ADD79A92
cites work	Classification of parenchymal abnormality in scleroderma lung using a novel approach to denoise images collected via a multicenter study Predictors of end stage lung disease in a cohort of patients with scleroderma Severe organ involvement in systemic sclerosis with diffuse scleroderma Interstitial lung disease in systemic sclerosis: a simple staging system Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee Preliminary criteria for the classification of systemic sclerosis (scleroderma) Predicting treatment outcomes and responder subsets in scleroderma-related interstitial lung disease Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis CXC chemokine ligand 4 (Cxcl4) is a platelet-derived mediator of experimental liver fibrosis Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosis. Scleroderma lung: initial forced vital capacity as predictor of pulmonary function decline Predictors of interstitial lung disease in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations Does C-reactive protein predict the long-term progression of interstitial lung disease and survival in patients with early systemic sclerosis? Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease. Prediction of pulmonary complications and long-term survival in systemic sclerosis Interstitial lung disease in systemic sclerosis Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial Serum CC chemokine ligand-18 predicts lung disease worsening in systemic sclerosis Elevated expression of platelet-derived chemokines in patients with antiphospholipid syndrome Serum CCL18 is predictive for lung disease progression and mortality in systemic sclerosis Low heme oxygenase-1 levels in patients with systemic sclerosis are associated with an altered Toll-like receptor response: another role for CXCL4?
author name string	wds:Q37547111-2227B929-7369-4B2F-9104-691FB9162444 wds:Q37547111-477AA912-F7DE-4CA0-97E4-C7671BE8B161 wds:Q37547111-5A7223DA-D7B7-47A3-B24B-139165BCFA99 wds:Q37547111-62778B49-9326-4B26-9100-A76B8C09A27A wds:Q37547111-6C7A9492-1E98-4880-A49F-C70D1A147B40 wds:Q37547111-949AE04D-628F-4762-975A-32C87D7B9DC2 wds:Q37547111-98C0107C-7A7B-4FC3-9109-F961CFED38BF wds:Q37547111-9909B97E-2E31-4560-AED2-B38CAE606774 wds:Q37547111-AFD28A55-36EF-476D-A53D-CDE75CEC5DF9 wds:Q37547111-D7150B25-879B-4319-AFD3-CFCE6E460F9E wds:Q37547111-EAF14019-786F-46F3-9D8E-66238A495201
author name string	Dinesh Khanna Chi-Hong Tseng Robert M Elashoff Shervin Assassi Donald P Tashkin Maureen Mayes Daniel E Furst Philip J Clements Michael D Roth Elizabeth R Volkmann Julio Charles
rdfs:label	Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis-related interstitial lung disease (en) Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis-related interstitial lung disease (nl) Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis-related interstitial lung disease (ast)
skos:prefLabel	Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis-related interstitial lung disease (en) Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis-related interstitial lung disease (nl) Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis-related interstitial lung disease (ast)
name	Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis-related interstitial lung disease (en)

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software